Gamble Jones Investment Counsel Has Lowered Gilead Sciences (GILD) Position; Central European Media Enterprises LTD (CETV)’s Sentiment Is 1.56

November 15, 2017 - By Kurt Siggers

Gamble Jones Investment Counsel decreased Gilead Sciences Inc (GILD) stake by 16.17% reported in 2017Q2 SEC filing. Gamble Jones Investment Counsel sold 4,294 shares as Gilead Sciences Inc (GILD)’s stock declined 8.05%. The Gamble Jones Investment Counsel holds 22,269 shares with $1.58 million value, down from 26,563 last quarter. Gilead Sciences Inc now has $92.92 billion valuation. The stock declined 0.43% or $0.3 reaching $70.85 per share. About 38,211 shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since November 15, 2016 and is downtrending. It has underperformed by 38.50% the S&P500.

Central European Media Enterprises Ltd. is a media and entertainment firm operating in Central and Eastern Europe. The company has market cap of $652.34 million. The Company’s assets are held through a series of Dutch and Curacao holding companies. It has a 44.73 P/E ratio. The Firm manages its business on a geographical basis, with six divisions: Bulgaria, Croatia, the Czech Republic, Romania, the Slovak Republic and Slovenia.

Tcs Capital Management Llc holds 37.65% of its portfolio in Central European Media Enterprises Ltd. for 18.14 million shares. Kamunting Street Capital Management L.P. owns 192,452 shares or 0.61% of their US portfolio. Moreover, Discovery Capital Management Llc Ct has 0.35% invested in the company for 3.56 million shares. The Georgia-based Vident Investment Advisory Llc has invested 0.02% in the stock. Putnam Investments Llc, a Massachusetts-based fund reported 617,722 shares.

It closed at $4.5 lastly. It is down 73.16% since November 15, 2016 and is uptrending. It has outperformed by 56.46% the S&P500.

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on February, 6. They expect $1.67 earnings per share, down 36.74% or $0.97 from last year’s $2.64 per share. GILD’s profit will be $2.19B for 10.61 P/E if the $1.67 EPS becomes a reality. After $2.23 actual earnings per share reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -25.11% negative EPS growth.

Gamble Jones Investment Counsel increased Powershares Qqq (QQQ) stake by 3,168 shares to 15,214 valued at $2.09M in 2017Q2. It also upped Spdr S&P 500 (SPY) stake by 1,432 shares and now owns 8,265 shares. Vanguard Short (VCSH) was raised too.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 18 have Buy rating, 0 Sell and 12 Hold. Therefore 60% are positive. Gilead Sciences has $137 highest and $7200 lowest target. $97.89’s average target is 38.17% above currents $70.85 stock price. Gilead Sciences had 106 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was downgraded by Credit Suisse to “Hold” on Tuesday, September 5. Atlantic Securities initiated it with “Neutral” rating and $111 target in Friday, December 18 report. The firm earned “Buy” rating on Thursday, September 28 by Mizuho. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Buy” rating by Citigroup on Friday, April 29. Maxim Group maintained it with “Buy” rating and $115 target in Friday, February 12 report. The stock has “Equal-Weight” rating by Morgan Stanley on Friday, October 2. BMO Capital Markets maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Friday, July 21 with “Hold” rating. The firm has “Outperform” rating by RBC Capital Markets given on Wednesday, November 2. The company was initiated on Monday, November 14 by Stifel Nicolaus. The firm has “Buy” rating given on Wednesday, June 1 by Gabelli.

Investors sentiment increased to 0.93 in Q2 2017. Its up 0.02, from 0.91 in 2017Q1. It increased, as 78 investors sold GILD shares while 538 reduced holdings. 110 funds opened positions while 462 raised stakes. 938.32 million shares or 0.11% more from 937.32 million shares in 2017Q1 were reported. Moreover, Strs Ohio has 0.45% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 1.41M shares. Peddock Cap Advisors Limited Liability Com accumulated 16,674 shares. The California-based Wetherby Asset Inc has invested 0.5% in Gilead Sciences, Inc. (NASDAQ:GILD). Gradient Investments Lc invested 0% in Gilead Sciences, Inc. (NASDAQ:GILD). Highland LP reported 0.16% stake. Rodgers Brothers accumulated 11,475 shares. Bb&T Securities Ltd holds 0.34% or 332,746 shares in its portfolio. Caisse De Depot Et Placement Du Quebec stated it has 2.16M shares. First Commonwealth Fincl Corp Pa reported 14,139 shares. Nordea Mngmt Ab has 0.18% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Comerica National Bank & Trust reported 449,500 shares. First Financial In accumulated 0.02% or 378 shares. Country Club Tru Co Na holds 0.04% or 3,830 shares in its portfolio. First Savings Bank has 0.21% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 17,317 shares. Stratos Wealth Limited, Ohio-based fund reported 77,452 shares.

Since June 1, 2017, it had 0 buys, and 2 sales for $5.11 million activity. On Thursday, June 1 MARTIN JOHN C sold $4.78M worth of Gilead Sciences, Inc. (NASDAQ:GILD) or 73,333 shares. Alton Gregg H also sold $325,114 worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Thursday, June 1.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com